PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

HomepageSociete Generaleq2-2024-Financial-Results-Presentation

q2-2024-Financial-Results-Presentation

Societe Generale

Browse presentations, reports, and documents from Societe Generale.

Tags

2024

Filter options

All (16)●
earnings (6)○
investor_presentation (1)○
presentation (9)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

q2-2024-Financial-Results-Presentation by Societe Generale.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Societe Generale

investor-presentation-sg-scf-sg-sfh-september-2023

presentation

premium-review-virtual-conference-presentation-03-12-2020

presentation

Similar presentations from other companies

1691592567_Investor%20Presentation%20Q1-FY2024

presentation

CARE Ratings Limited

Access-Holdings-FY-2022-Presentation

presentation

Access Holding

q2-2024-Financial-Results-Presentation - Societe Generale | Presentation Nation

q1-2023-financial-results-presentation

presentation

q1-2024-debt-investor-presentation

presentation

q2-2024-debt-investor-presentation

presentation

q3-2021-financial-results-presentation

presentation

Appian Corporation_Q2 2021_141_73141

presentation

Appian Corporation

b91df7fa-2d56-481d-9e7a-91309c1db49e

presentation

Maxeon Solar Technologies

Bank7%20Corp%20Q4%20and%20Full%20Year%202021%20Earnings%20Slide%20Deck.PDF

presentation

Bank7 Corporation

Caladrius Biosciences_January_2020_417_50417

presentation

Caladrius Biosciences